Maravai LifeSciences Holdings, Inc.
MRVI
$1.77
$0.052.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.69% | -0.25% | -0.07% | -10.60% | -9.04% |
| Total Receivables | -29.59% | -41.32% | -20.24% | -30.52% | -62.06% |
| Inventory | -2.56% | 2.58% | 3.99% | -9.07% | 19.11% |
| Prepaid Expenses | -9.96% | -5.49% | -24.21% | -34.13% | -30.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -38.69% | -3.11% | -1.99% | -12.75% | -17.45% |
|
|
|||||
| Total Current Assets | -38.69% | -3.11% | -1.99% | -12.75% | -17.45% |
| Net Property, Plant & Equipment | -2.52% | -23.97% | -19.90% | 4.37% | 90.96% |
| Long-term Investments | -50.96% | -47.31% | -0.13% | -0.17% | 14.93% |
| Goodwill | -50.96% | -47.31% | -0.13% | -0.17% | 14.93% |
| Total Other Intangibles | -11.78% | -11.41% | -11.71% | -11.37% | 2.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.31% | -92.22% | -91.90% | -90.82% | -98.84% |
| Total Assets | -32.22% | -43.63% | -36.07% | -37.61% | -34.83% |
|
|
|||||
| Total Accounts Payable | 11.45% | 0.74% | 88.28% | 71.95% | 79.09% |
| Total Accrued Expenses | -3.53% | -45.09% | -39.40% | -39.15% | -18.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.69% | 2.56% | 2.71% | 4.77% | 9.77% |
| Total Finance Division Other Current Liabilities | -90.57% | 98.52% | 37.89% | -78.51% | -38.88% |
| Total Other Current Liabilities | -90.57% | 98.52% | 37.89% | -78.51% | -38.88% |
| Total Current Liabilities | -34.87% | -19.18% | -8.50% | -52.74% | -20.59% |
|
|
|||||
| Total Current Liabilities | -34.87% | -19.18% | -8.50% | -52.74% | -20.59% |
| Long-Term Debt | -44.00% | -0.62% | -0.63% | -0.63% | -0.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.71% | 1.91% | 1.00% | 25.08% | 54.02% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -7.50% | -99.72% | -99.90% | -99.63% | -98.27% |
| Total Liabilities | -38.21% | -51.64% | -50.89% | -52.84% | -49.34% |
|
|
|||||
| Common Stock & APIC | 40.75% | 39.58% | 39.58% | 17.28% | -6.72% |
| Retained Earnings | -50.69% | -57.36% | -33.17% | -32.38% | -29.41% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -21.95% | -33.54% | -16.07% | -21.26% | -23.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.95% | -33.54% | -16.07% | -21.26% | -23.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -32.49% | -28.15% | -9.97% | -3.27% | 3.64% |
| Total Equity | -26.92% | -31.29% | -13.50% | -13.68% | -12.74% |
|
|
|||||